1). Delta-Fly is planning to test DFP-17729 in combination with gemcitabine in patients with advanced pancreatic cancer and with an anti-programmed cell death 1 antibody in advanced gastric cancer.

Regarding the Phase I/II clinical trial of DFP-10917 in combination with Venetoclax ... to the Phase II portion of the trial for efficacy testing as of today, on 28 th Feb., 2025.

Regarding the Phase I/II clinical trial of DFP-10917 in combination with Venetoclax (VEN ... and we are moving to the Phase II portion of the trial for efficacy testing as of today, on 28 th Feb., ...